Results 161 to 170 of about 11,777 (217)

[Influence of the intravenous nitroglycerin dose on the appearance of drug tolerance].

Medicina clinica, 1995
There are few studies on the influence of different doses of intravenous nitroglycerin (NTG) on the appearance of drug tolerance.A controlled clinical trial was performed in 40 patients admitted to an ICU with the diagnosis of acute myocardial infarction (AMI).
F, Barranco, A, Lesmes, J, Irles, L, Peñas, S, Schiaffino, J, Ballesteros, J, Pomares   +6 more
openaire   +1 more source

Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.

Archives of internal medicine, 1990
The purpose of this randomized crossover study was to determine whether nitroglycerin interacts with heparin in terms of its anticoagulative properties as determined by activated partial thromboplastin time and thrombin time. Eight healthy adults were given either a 60-minute intravenous infusion of 5 mg of nitroglycerin or a 0.9% sodium chloride ...
V, Bode, D, Welzel, G, Franz, U, Polensky   +3 more
openaire   +1 more source

Drug release rates from four sizes of a new transdermal nitroglycerin adhesive patch.

Clinical therapeutics, 1989
This study was conducted to determine the amount of nitroglycerin released from transdermal nitroglycerin patches of four different sizes: 3.3 cm2, 6.7 cm2, 13.3 cm2, and 20 cm2. Thirty healthy men received a single 24-hour application of each patch size according to a randomized, open-label, four-period crossover design.
D J, Riedel, K A, Wick, R W, Hawkinson, C A, Kolars, J K, Crowley, L I, Harrison, S R, de Dennis   +6 more
openaire   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Antianginal drugs. Part III. Clinical use of nitroglycerin

American Heart Journal, 1966
openaire   +2 more sources

Effects of Two Drugs (Molsidomine and nitroglycerin) on Prostacyclin Secretion in Piglet Endothelial Cells in Culture

, 1983
B. Poincelot, F Russo-Marie
openalex   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly